Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,174.57
(
0.13%
)
US TECH 100
26,543.20
(
-0.05%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
101.56
(
0.03%
)
Bitcoin
76,585.12
(
-2.63%
)
News Focus
News Focus
Post# of 257448
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122891
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 119176

Monday, 05/02/2011 8:36:28 AM

Monday, May 02, 2011 8:36:28 AM

Post# of 257448

There's no question in my mind that Teva is trying to relieve the impact of generic Copaxone.

Yes, all the pieces are falling into place, including Teva’s never mentioning Lovenox again to the investment community (#msg-61955835, third paragraph).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today